CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
2023 · Nature Cancer · 120 citations
https://doi.org/10.1038/s43018-023-00600-4
V
Vincent M. D’Anniballe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
212
Citations
6
h-index
4
i10-index
Vincent M. D’Anniballe is an academic researcher. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cytokine Signaling Pathways and Interactions & Cancer Immunotherapy and Biomarkers. The author has an h-index of 6, co-authored 42 publications.
ORCID: 0000-0002-8536-633XPapers by this author
worksIntratumoural immunotherapy plus focal thermal ablation for localized prostate cancer
2023 · Nature Reviews Urology · 19 citations
https://doi.org/10.1038/s41585-023-00834-y
Multi-label annotation of text reports from computed tomography of the chest, abdomen, and pelvis using deep learning
2022 · BMC Medical Informatics and Decision Making · 7 citations
https://doi.org/10.1186/s12911-022-01843-4
Figure S3 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727851
Figure S5 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727842
Figure S4 from Peripheral Blood IFN Responses to Toll-Like Receptor 1/2 Signaling Associate with Longer Survival in Men with Metastatic Prostate Cancer Treated with Sipuleucel-T
2025 · 0 citations
https://doi.org/10.1158/2767-9764.28727848
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat